Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease
figureposted on 2020-04-14, 15:42 authored by Cristian Guja, Juan P. Frías, Lisa Suchower, Elise Hardy, Galina Marr, C. David Sjöström, Serge A. Jabbour
The above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.